UNIVAR INC. 12,500,000 SHARES OF COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • December 15th, 2016 • Univar Inc. • Wholesale-chemicals & allied products • New York
Contract Type FiledDecember 15th, 2016 Company Industry JurisdictionThe holders named in Schedule I hereto (the “Selling Stockholders”) of Univar Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to Goldman, Sachs & Co. (the “Underwriter”) an aggregate of 12,500,000 shares (the “Shares”) $0.01 par value (the “Stock”) of the Company.
Underwriting AgreementUnderwriting Agreement • March 9th, 2015 • Envision Healthcare Holdings, Inc. • Services-general medical & surgical hospitals, nec • New York
Contract Type FiledMarch 9th, 2015 Company Industry JurisdictionThe investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC named in Schedule I hereto (the “Selling Stockholders”) as stockholders of Envision Healthcare Holdings, Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to Barclays Capital Inc. (the “Underwriter”) an aggregate of 50,857,145 shares (the “Shares”) of Common Stock, $0.01 par value (“Stock”) of the Company.
Underwriting AgreementUnderwriting Agreement • September 29th, 2014 • Envision Healthcare Holdings, Inc. • Services-general medical & surgical hospitals, nec • New York
Contract Type FiledSeptember 29th, 2014 Company Industry JurisdictionThe investment funds sponsored by, or affiliated with, Clayton, Dubilier & Rice, LLC named in Schedule I(a) hereto (the “CD&R Affiliates”) and the executive officers and directors of Envision Healthcare Holdings, Inc., a Delaware corporation (the “Company”), named in Schedule I(b) hereto (the “Management Selling Stockholders” and, together with the CD&R Affiliates, the “Selling Stockholders”) as stockholders of the Company, propose, subject to the terms and conditions stated herein, to sell to Citigroup Global Markets Inc. (the “Underwriter”) an aggregate of 17,500,000 shares (the “Shares”) of Common Stock, $0.01 par value (“Stock”) of the Company.